Elsa Mühlbacher

Title: Innovations by Elsa Mühlbacher in Cytomegalovirus Vaccines

Introduction

Elsa Mühlbacher is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of biotechnology, particularly in the development of vaccines for cytomegalovirus (CMV) infections. With a total of two patents to her name, her work is paving the way for advancements in medical treatments.

Latest Patents

Mühlbacher's latest patents focus on genetically modified arenaviral vectors that are suitable as vaccines for the prevention and treatment of cytomegalovirus infections and reactivation. These patents also include pharmaceutical compositions and methods aimed at treating CMV infections. Specifically, her work provides innovative solutions for the development of effective vaccines and treatment methods for this viral infection.

Career Highlights

Elsa Mühlbacher is currently associated with Hookipa Biotech GmbH, where she continues to push the boundaries of vaccine research. Her expertise in biotechnology and her commitment to improving public health through innovative solutions are commendable.

Collaborations

Mühlbacher collaborates with notable colleagues such as Klaus Orlinger and Karen Lingnau, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Elsa Mühlbacher's work in the field of CMV vaccines exemplifies the impact of innovative research on public health. Her contributions are vital in the ongoing fight against viral infections, and her patents represent significant advancements in vaccine technology.